May 16, 2011 (Marketwire Canada) --
VANCOUVER, BRITISH COLUMBIA -- EnWave Corporation (TSX VENTURE:ENW)(FRANKFURT:E4U) ("EnWave", or the "Company") today announced that it has signed a commercial license agreement ("the Agreement") with Milne Fruit Products Inc. ("Milne Fruit"), a leading American fruit processor, to supply Radiant Energy Vacuum ("REV") technology for the dehydration of a variety of specified fruit products. The Agreement includes a provision for royalty payments on nutraDried™ fruit products produced using EnWave's technology. A MIVAP™ dehydrator has been purchased for its new plant.
"This agreement represents a further step forward in the commercial introduction of EnWave's proprietary dehydration technology into the North American food processing sector," said Dr. Tim Durance, Co-CEO, EnWave Corporation. "Milne Fruit supplies fruit products to some of North America's largest food companies, and they are well known for the quality of their products."
EnWave's dehydration technologies for food include nutraREV™, MIVAP™ and quantaREV™, with each employing a combination of vacuum and microwave energy to deliver a high-speed, low-temperature food dehydration process. The technologies can be used to dry a wide variety of fruit, vegetables, herbs, meats and seafood at, or below, 37°C (98°F) in order to maintain high levels of nutrition, flavour, colour and texture. nutraREV™ is being introduced globally as an alternative technology to freeze drying and air drying for the development of nutraDried™ snack foods, baked goods and ingredients.
About Milne Fruit Products Inc.
Located in Prosser, Washington, Milne Fruit was started in 1956 as a quality processor and purveyor of fruit-based ingredients. Milne Fruit supplies a diverse offering of fruit purees, juices, concentrates, extracts, powders and mixes to the North American food processing sector. More information about the company is available at: http://www.milnefruit.com.
EnWave Corporation is a Vancouver-based industrial technology company developing commercial applications for its proprietary Radiant Energy Vacuum (REV) technology. REV is used to dehydrate food, bulk liquids, and pharmaceuticals, and the Company's mission is to establish the technology as a new dehydration standard which results in a better end product quality than air drying or spray drying. EnWave currently has six REV platforms: commercial-scale nutraREV™ and MIVAP™ are used in the food industry to dry fruits, vegetables, meat, herbs and seafood quickly while maintaining high levels of nutrition, taste, texture and colour. The Company is also developing powderREV™ for bulk dehydration of food cultures, probiotics and fine biochemicals such as enzymes; quantaREV™ for continuous, high-volume low-temperature drying of pastes, gels, liquids, or particulates; and bioREV™ and freezeREV™ as new methods to stabilize and dehydrate biopharmaceuticals such as vaccines and antibodies. More information about EnWave is available at www.enwave.net.
Dr. Tim Durance, Chairman & Co-CEO
Safe Harbour for Forward-Looking Information Statements: This press release may contain forward-looking information based on management's expectations, estimates and projections. All statements that address expectations or projections about the future, including statements about the Company's strategy for growth, product development, market position, expected expenditures and financial results are forward-looking statements. These statements are not a guarantee of future performance and involve a number of risks, uncertainties and assumptions. There is no guarantee that the Company's REV technology can or will improve processes in the target industry; even if the Company's REV technology can be used as described in this document, there is no guarantee that such use will result in orders for the Company's REV technology. All figures comparing REV technologies to freeze drying or other dehydration technologies are provided as examples of data obtained through the Company's own scientific and testing programs; each product must be tested individually to determine the benefits of using REV.
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
President & Co-CEO
V.P. Corporate Development & Investor Relations